Narcolepsy is a sleep disorder that involves excessive daytime sleepiness (a “sleep attack”). Cataplexy is a sudden, temporary loss of voluntary muscle control that may be triggered by a strong emotion (like laughter).
A new clinical research study is looking at how safe an investigational medication is, and how well it works, for cataplexy and excessive daytime sleepiness in people who have narcolepsy with cataplexy (narcolepsy type 1).
For patients who meet the study criteria, the trial will last up to 22 weeks. All study medication and study-related procedures will be provided at no cost to you. The study will involve visits to a study site.
Sign up to take part in a clinical trial. You can learn more and begin the qualification process at https://trials.autocruitment.com/forms/NarcolepsyStudy15-006_CC/
